Trade EWTX anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Edgewise Therapeutics, Inc. (EWTX) is trading at US$41.98, up 0.06% today as of Sep 4, 10:27 EDT. The company has a market capitalisation of US$4.8B. Over the past 52 weeks, EWTX has traded between US$13.69 and US$48.40. On Syfe you can trade EWTX with $0 commission and add it to your watchlist.
| Previous close | US$41.95 |
|---|---|
| Market cap | US$4.8B |
| 52-week range | US$13.69 – US$48.40 |
| Volume | 898.74K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The firm focuses on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need. Its platform utilizes custom-built throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue, initially focused on addressing rare neuromuscular and cardiac diseases. The company was founded by Badreddin Edris, Alan Russel and Peter A. Thompson in 2017 and is headquartered in Boulder, CO.
Year: 2021
Edgewise Therapeutics' EDG-7500 Seen Entering 'Catalyst-Dense' Regulatory Period, Oppenheimer Says
Jul 9, 3:17 PM · MT Newswires
Oppenheimer Initiates Edgewise Therapeutics at Outperform
Jul 9, 12:19 PM · MT Newswires
Edgewise Therapeutics Remains Compelling Cardiology Story Despite Atrial Fibrillation Concerns, RBC Says
Jun 17, 3:02 PM · MT Newswires
RBC Raises Price Target on Edgewise Therapeutics to $59 From $48, Keeps Outperform, Speculative Risk
Jun 17, 10:42 AM · MT Newswires
Edgewise Therapeutics, Inc. (EWTX) stock is trading at US$41.98, +0.06% from the previous close of US$41.95.
The market cap for Edgewise Therapeutics, Inc. (EWTX) stock is approximately US$4.8B.
The 52-week high for Edgewise Therapeutics, Inc. (EWTX) stock is US$48.40.
The 52-week low for Edgewise Therapeutics, Inc. (EWTX) stock is US$13.69.
Edgewise Therapeutics, Inc. (EWTX) does not currently pay a dividend.
Stay on top of EWTX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
